Luce BR - Search Results

1

Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial Execution.

Luce BR, Connor JT, Broglio KR, Mullins CD, Ishak KJ, Saunders E, Davis BR; RE-ADAPT (REsearch in ADAptive methods for Pragmatic Trials) Investigators. Luce BR, et al. Ann Intern Med. 2016 Sep 20;165(6):431-8. doi: 10.7326/M15-0823. Epub 2016 Jun 7. Ann Intern Med. 2016. PMID: 27273013

2

Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study.

Connor JT, Luce BR, Broglio KR, Ishak KJ, Mullins CD, Vanness DJ, Fleurence R, Saunders E, Davis BR. Connor JT, et al. Among authors: luce br. Clin Trials. 2013 Oct;10(5):807-27. doi: 10.1177/1740774513497293. Epub 2013 Aug 27. Clin Trials. 2013. PMID: 23983160 Free PMC article.

3

Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.

Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Luce BR, et al. Ann Intern Med. 2009 Aug 4;151(3):206-9. doi: 10.7326/0003-4819-151-3-200908040-00126. Epub 2009 Jun 30. Ann Intern Med. 2009. PMID: 19567619 Free article. No abstract available.

4

The Patient-centered Outcomes Research Institute's Role in Advancing Methods for Patient-centered Outcomes Research.

Fleurence R, Whicher D, Dunham K, Gerson J, Newhouse R, Luce B. Fleurence R, et al. Med Care. 2015 Jan;53(1):2-8. doi: 10.1097/MLR.0000000000000244. Med Care. 2015. PMID: 25334055 Free PMC article. No abstract available.

5

Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease.

Stergachis A, Sheingold S, Luce BR, Psaty BM, Revicki DA. Stergachis A, et al. Among authors: luce br. Arch Intern Med. 1992 Jun;152(6):1220-4. Arch Intern Med. 1992. PMID: 1599350

6

How different is research done by the Patient-centered Outcomes Research Institute, and what difference does it make?

Luce BR, Simeone JC. Luce BR, et al. J Comp Eff Res. 2019 Oct;8(14):1239-1251. doi: 10.2217/cer-2019-0054. Epub 2019 Aug 22. J Comp Eff Res. 2019. PMID: 31436471 Free article.

7

Can managed care organizations partner with manufacturers for comparative effectiveness research?

Luce BR, Paramore LC, Parasuraman B, Liljas B, de Lissovoy G. Luce BR, et al. Am J Manag Care. 2008 Mar;14(3):149-56. Am J Manag Care. 2008. PMID: 18333707 Free article.

8

Principles for planning and conducting comparative effectiveness research.

Luce BR, Drummond MF, Dubois RW, Neumann PJ, Jönsson B, Siebert U, Schwartz JS. Luce BR, et al. J Comp Eff Res. 2012 Sep;1(5):431-40. doi: 10.2217/cer.12.41. J Comp Eff Res. 2012. PMID: 24236420 Free article.

9

EBM, HTA, and CER: clearing the confusion.

Luce BR, Drummond M, Jönsson B, Neumann PJ, Schwartz JS, Siebert U, Sullivan SD. Luce BR, et al. Milbank Q. 2010 Jun;88(2):256-76. doi: 10.1111/j.1468-0009.2010.00598.x. Milbank Q. 2010. PMID: 20579285 Free PMC article.

10

Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?

International Working Group for HTA Advancement; Neumann PJ, Drummond MF, Jönsson B, Luce BR, Schwartz JS, Siebert U, Sullivan SD. International Working Group for HTA Advancement, et al. Among authors: luce br. Int J Technol Assess Health Care. 2010 Jan;26(1):71-8. doi: 10.1017/S0266462309990833. Int J Technol Assess Health Care. 2010. PMID: 20059783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page